Complete regression of posttransplant lymphoproliferative disease using partially HLA-matched epstein barr virus-specific cytotoxic T cells

Transplantation

Volumn 72, Issue 8, 2001, Pages 1352-1353

  Haque, T ^a   Taylor, C ^a   Wilkie, G M ^a   Murad, P ^a   Amlot, P L ^a   Beath, S ^a   McKiernan, P J ^a   Crawford, D H ^a   Khanna, A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; GANCICLOVIR; IMMUNOSUPPRESSIVE AGENT; MONOCLONAL ANTIBODY; VIRUS ANTIGEN; AZATHIOPRINE; PREDNISOLONE; TACROLIMUS; VALACICLOVIR;

ADOPTIVE IMMUNOTHERAPY; CYTOTOXIC T LYMPHOCYTE; EPSTEIN BARR VIRUS; HLA MATCHING; HUMAN; IMMUNE DEFICIENCY; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; KILLER CELL; LYMPHOPROLIFERATIVE DISEASE; MONONUCLEAR CELL; NOTE; PATIENT CARE; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE; PRIORITY JOURNAL; STEM CELL; ARTICLE; CASE REPORT; DILUTION; IMMUNOPROPHYLAXIS; INTESTINE TRANSPLANTATION; LIVER TRANSPLANTATION; MALE; SCHOOL CHILD;

EID: 0035960318     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200110270-00003     Document Type: Note

References (6)

1. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steriod therapy
2. Indications and results of chemotherapy in children with posttransplant lymphoproliferative disease after liver transplantation
3. Treatment of B cell lymphoproliferative disorders with interferon alpha and intravenous gamma globulin
4. Anti B cell monoclonal antibodies in the treatment of severe B cell lymphoproliferative syndrome following bone marrow and organ transplantation
5. Autologous lymphokine-activated killer cell therapy of Epstein-Barr virus-positive and -negative lymphoproliferative disorders arising in organ transplant recipients
6. Activation and adoptive transfer of Epstein-Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease